Ilari Scheinin
Ilari Scheinin
Affiliation inconnue
Adresse e-mail validée de helsinki.fi
Titre
Citée par
Citée par
Année
Chipster: user-friendly analysis software for microarray and other high-throughput data
MA Kallio, JT Tuimala, T Hupponen, P Klemelä, M Gentile, I Scheinin, ...
BMC genomics 12 (1), 507, 2011
2662011
DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly
I Scheinin, D Sie, H Bengtsson, MA Van De Wiel, AB Olshen, ...
Genome research 24 (12), 2022-2032, 2014
1822014
Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes
S Myllykangas, S Junnila, A Kokkola, R Autio, I Scheinin, T Kiviluoto, ...
International journal of cancer 123 (4), 817-825, 2008
952008
CanGEM: mining gene copy number changes in cancer
I Scheinin, S Myllykangas, I Borze, T Böhling, S Knuutila, J Saharinen
Nucleic acids research 36 (suppl_1), D830-D835, 2007
392007
Landscape of chromosomal copy number aberrations in gangliogliomas and dysembryoplastic neuroepithelial tumours
AS Prabowo, HF van Thuijl, I Scheinin, D Sie, HF van Essen, AM Iyer, ...
Neuropathology and Applied Neurobiology 41 (6), 743-755, 2015
352015
Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas
HF van Thuijl, I Scheinin, D Sie, A Alentorn, HF van Essen, M Cordes, ...
Genome biology 15 (9), 1-13, 2014
272014
miRNA expression profiles in myelodysplastic syndromes reveal Epstein–Barr virus miR-BART13 dysregulation
I Borze, I Scheinin, S Siitonen, E Elonen, E Juvonen, S Knuutila
Leukemia & lymphoma 52 (8), 1567-1573, 2011
182011
Targeted resequencing of 9p in acute lymphoblastic leukemia yields concordant results with array CGH and reveals novel genomic alterations
VK Sarhadi, L Lahti, I Scheinin, A Tyybäkinoja, S Savola, A Usvasalo, ...
Genomics 102 (3), 182-188, 2013
172013
Copy number alterations and neoplasia‐specific mutations in MELK, PDCD1LG2, TLN1, and PAX5 at 9p in different neoplasias
VK Sarhadi, L Lahti, I Scheinin, P Ellonen, E Kettunen, M Serra, ...
Genes, Chromosomes and Cancer 53 (7), 579-588, 2014
152014
High-resolution SNP array analysis of patients with developmental disorder and normal array CGH results
L Siggberg, AM Sirpa, L Tarja, A Kristiina, S Ilari, K Kati, L Päivi, H Marja, ...
BMC medical genetics 13 (1), 84, 2012
152012
Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas
A Alentorn, HF van Thuijl, Y Marie, H Alshehhi, C Carpentier, B Boisselier, ...
Neuro-oncology 16 (3), 400-408, 2014
92014
CGHpower: exploring sample size calculations for chromosomal copy number experiments
I Scheinin, JA Ferreira, S Knuutila, GA Meijer, MA van de Wiel, B Ylstra
BMC bioinformatics 11 (1), 1-10, 2010
82010
New insights into the cellular pathways affected in primary uterine leiomyosarcoma
S Kaur, ML Larramendy, M Gentile, C Svarvar, R Koivisto-Korander, ...
Cancer Genomics-Proteomics 3 (6), 347-354, 2006
52006
Homozygous deletions of cadherin genes in chondrosarcoma—an array comparative genomic hybridization study
T Niini, I Scheinin, L Lahti, S Savola, F Mertens, J Hollmén, T Böhling, ...
Cancer genetics 205 (11), 588-593, 2012
32012
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–14